Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Role of IL-17 and Th17 cells in liver diseases.
Hammerich L, Heymann F, Tacke F. Hammerich L, et al. Among authors: heymann f. Clin Dev Immunol. 2011;2011:345803. doi: 10.1155/2011/345803. Epub 2010 Dec 15. Clin Dev Immunol. 2011. PMID: 21197451 Free PMC article. Review.
Peptide-functionalized gold nanorods increase liver injury in hepatitis.
Bartneck M, Ritz T, Keul HA, Wambach M, Bornemann J, Gbureck U, Ehling J, Lammers T, Heymann F, Gassler N, Lüdde T, Trautwein C, Groll J, Tacke F. Bartneck M, et al. Among authors: heymann f. ACS Nano. 2012 Oct 23;6(10):8767-77. doi: 10.1021/nn302502u. Epub 2012 Oct 1. ACS Nano. 2012. PMID: 22994679
Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.
Baeck C, Wei X, Bartneck M, Fech V, Heymann F, Gassler N, Hittatiya K, Eulberg D, Luedde T, Trautwein C, Tacke F. Baeck C, et al. Among authors: heymann f. Hepatology. 2014 Mar;59(3):1060-72. doi: 10.1002/hep.26783. Epub 2014 Jan 30. Hepatology. 2014. PMID: 24481979
47 results